Chwan-Fwu Lin1, Chi-Feng Hung2, Ibrahim A Aljuffali3, Yu-Ling Huang1,4, Wei-Chun Liao5, Jia-You Fang6,7,8,9. 1. Department of Cosmetic Science, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan. 2. School of Medicine, Fu Jen Catholic University, Hsinchuang, New Taipei City, Taiwan. 3. Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. 4. National Research Institute of Chinese Medicine, Taipei, Taiwan. 5. Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan. 6. Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan. fajy@mail.cgu.edu.tw. 7. Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, 259 Wen-Hwa 1st Road, Kweishan, Taoyuan, 333, Taiwan. fajy@mail.cgu.edu.tw. 8. Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Kweishan, Taoyuan, Taiwan. fajy@mail.cgu.edu.tw. 9. Department of Anesthesiology, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan. fajy@mail.cgu.edu.tw.
Abstract
PURPOSE: As a continuing effort to elucidate the impact of structure modification upon cutaneous absorption behavior, we attempted to assess the skin permeation of magnolol by methylation and acetylation. METHODS: Diacetylmagnolol and 2-O-acetyl-2'-O-methylmagnolol (AMM) were designed and synthesized in this study. The anti-inflammatory activity against stimulated neutrophils and keratinocytes was evaluated to check the bioactivity of the analogues. In vitro skin absorption was investigated using nude mouse and pig skin models at both equimolar and saturated doses. RESULTS: Magnolol generally showed the strongest anti-inflammatory potential, followed by diacetylmagnolol and AMM. The antibacterial activity was observed for magnolol and diacetylmagnolol but not AMM. Diacetylmagnolol and AMM could be partly hydrolyzed to magnolol and 2-O-methylmagnolol after entering the skin. The hydrolysis rate of diacetylmagnolol was faster than that of AMM. The lipophilicity played a crucial role in cutaneous absorption, with AMM exhibiting the highest skin deposition. AMM accumulation within nude mouse skin was about 2.5-fold greater than that of magnolol and diacetylmagnolol. On the other hand, the transdermal penetration across the skin was lessened by methylation and esterification. This led to a superior skin targeting of AMM. Although the pharmacological activity of AMM was low, the high skin uptake and bioconversion into 2-O-methylmagnolol in the skin contributed to a greater therapeutic index (TI, skin deposition x inflammatory inhibition percentage) compared to the others. The accumulation of AMM in the hair follicles was 77.12 nmol/cm(2), which was significantly greater than that with magnolol (44.84 nmol/cm(2)) and diacetylmagnolol (26.96 nmol/cm(2)). The synthetic analogues were tolerable to the nude mouse skin. CONCLUSIONS: Based on the experimental results, we may suggest topically applied AMM as a potent and safe candidate for the treatment of cutaneous inflammation.
PURPOSE: As a continuing effort to elucidate the impact of structure modification upon cutaneous absorption behavior, we attempted to assess the skin permeation of magnolol by methylation and acetylation. METHODS:Diacetylmagnolol and 2-O-acetyl-2'-O-methylmagnolol (AMM) were designed and synthesized in this study. The anti-inflammatory activity against stimulated neutrophils and keratinocytes was evaluated to check the bioactivity of the analogues. In vitro skin absorption was investigated using nude mouse and pig skin models at both equimolar and saturated doses. RESULTS:Magnolol generally showed the strongest anti-inflammatory potential, followed by diacetylmagnolol and AMM. The antibacterial activity was observed for magnolol and diacetylmagnolol but not AMM. Diacetylmagnolol and AMM could be partly hydrolyzed to magnolol and 2-O-methylmagnolol after entering the skin. The hydrolysis rate of diacetylmagnolol was faster than that of AMM. The lipophilicity played a crucial role in cutaneous absorption, with AMM exhibiting the highest skin deposition. AMM accumulation within nude mouse skin was about 2.5-fold greater than that of magnolol and diacetylmagnolol. On the other hand, the transdermal penetration across the skin was lessened by methylation and esterification. This led to a superior skin targeting of AMM. Although the pharmacological activity of AMM was low, the high skin uptake and bioconversion into 2-O-methylmagnolol in the skin contributed to a greater therapeutic index (TI, skin deposition x inflammatory inhibition percentage) compared to the others. The accumulation of AMM in the hair follicles was 77.12 nmol/cm(2), which was significantly greater than that with magnolol (44.84 nmol/cm(2)) and diacetylmagnolol (26.96 nmol/cm(2)). The synthetic analogues were tolerable to the nude mouse skin. CONCLUSIONS: Based on the experimental results, we may suggest topically applied AMM as a potent and safe candidate for the treatment of cutaneous inflammation.
Authors: Christopher S J Campbell; L Rodrigo Contreras-Rojas; M Begoña Delgado-Charro; Richard H Guy Journal: J Control Release Date: 2012-06-23 Impact factor: 9.776
Authors: Phan Van Kiem; Mai Dinh Tri; Le Vo Dinh Tuong; Nguyen Huu Tung; Nguyen Ngoc Hanh; Tran Hong Quang; Nguyen Xuan Cuong; Chau Van Minh; Eun-Mi Choi; Young Ho Kim Journal: Chem Pharm Bull (Tokyo) Date: 2008-09 Impact factor: 1.645
Authors: Khalifa El Malki; Susanne H Karbach; Jula Huppert; Morad Zayoud; Sonja Reissig; Rebecca Schüler; Alexej Nikolaev; Khalad Karram; Thomas Münzel; Christoph R W Kuhlmann; Heiko J Luhmann; Esther von Stebut; Simone Wörtge; Florian C Kurschus; Ari Waisman Journal: J Invest Dermatol Date: 2012-09-06 Impact factor: 8.551